Oncologist expands HPV research to anal cancer

January 16, 2013, Women & Infants Hospital

A basic connection of statistics lead a researcher at Women & Infants Hospital of Rhode Island to question whether women should be screened for anal cancer during a regular visit to the gynecologist, and what technique is most effective.

is rare in the United States, with only about 3,200 new cases in estimated in 2010, but it is one of the few cancers where the numbers have been steadily rising. Existing research has also demonstrated an association between anal cancer and the human papilloma virus (HPV), which is a known cause of cervical cancer. In fact, HPV infection is related to 90% of anal cancers in women, which suggests that the majority of anal cancers could be prevented with the HPV vaccine.

Katina Robison, MD, a gynecologic oncologist with Women & Infants' Program in Women's Oncology and one of the hospital's Women's Reproductive Health Research (WRHR) Scholars, has launched recruitment for her new study, "Anal cytology and HPV genotyping in women with lower genital tract neoplasia." The two-year study is funded by a $20,000 seed grant from the Brown University Center for Women's Excellence.

"There is no literature currently suggesting how this should be handled in the general population. Should we test everyone? Who is at risk?" Dr. Robison said. "My goal is to gather basic information that I can use to design a larger, multi-site study that will analyze the sensitivity and specificity of anal cytology, which is basically a Pap of the anus, with the possible addition of HPV testing, to screen at-risk women."

Laying the groundwork

There are three goals to the current study:

  • To determine the prevalence of abnormal anal cytology among women with a recent history of cervical, vulvar or vaginal high-grade pre-cancer or cancer
  • To determine the prevalence of high-risk anal HPV among women with a recent history of cervical, vulvar or vaginal high-grade pre-cancer or cancer
  • To compare the prevalence of abnormal anal cytology and high-risk HPV between at-risk and low-risk women
"I believe there will be a higher prevalence of high-risk HPV and possibly a higher prevalence of abnormal anal cytology among women who have recently had HPV-related gynecologic cancer," Dr. Robison asserted.

If her hypotheses are correct, it could change the way gynecologists conduct regular examinations of their patients with a history of cervical pre-cancer or cancer. Currently, they perform detailed exams of the vulva and vagina in these women, but do not routinely examine the anus.

"The goal of screening is to detect and treat anal dysplasia early, thereby preventing anal cancers," Dr. Robison said, adding that screening can be as simple as a Pap test designed for the anus.

Studying women

Women will be considered eligible for the study if they are over 18 and have had a diagnosis of cervical, vulvar or vaginal cancer diagnosed through a biopsy within two years.

Dr. Robison hopes to enroll a total of 348 women with cancer and an additional 116 control subjects in the study. They will be recruited through the Program in Women's Oncology and the hospital's Center for Primary Care.

All participants will undergo cervical and anal cytologic screening and HPV genotype evaluation of the cervix, vulva and anus. Patients with cervical and anal cytologic abnormalities will be managed according to American Cancer Society guidelines. If an abnormal anal cytology is discovered, the patient will be referred to the Rhode Island Colorectal clinic.

"By looking at a larger group with a control, we'll be able to better decide if everyone should have anal cancer screenings. We will also be able to determine if HPV testing may be a useful screening tool," Dr. Robison said.

Explore further: HIV raises anal cancer risk in women, study says

Related Stories

HIV raises anal cancer risk in women, study says

April 16, 2012
(HealthDay) -- Women with HIV are at increased risk for anal cancer, a new study finds.

Cervical vaccine also protects against anal cancer risk

August 23, 2011
A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.

Most anal lesions don't cause cancer in men, research shows

March 23, 2012
(HealthDay) -- Anal human papillomavirus (HPV) infection and precancerous lesions are common among gay and bisexual men, but most of these cases will not progress to anal cancer, a new analysis of earlier research shows.

HIV helps explain rise of anal cancer in US males

October 6, 2012
The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.